Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
29.91
+0.02 (0.07%)
At close: Jul 2, 2026, 4:00 PM EDT
29.80
-0.11 (-0.37%)
After-hours: Jul 2, 2026, 7:26 PM EDT

Legend Biotech Revenue

Legend Biotech had revenue of $305.10M in the quarter ending March 31, 2026, with 56.46% growth. This brings the company's revenue in the last twelve months to $1.14B, up 56.38% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+56.38%
P/S Ratio
5.08
Revenue / Employee
$384,148
Employees
2,965
Market Cap
5.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Caris Life Sciences907.29M
Travere Therapeutics536.20M
Ligand Pharmaceuticals274.48M
Xenon Pharmaceuticals7.50M
CG Oncology5.07M
CRISPR Therapeutics AG4.10M
Revenue Rankings

LEGN News

More News